Drugs / Microbiota capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07496502 | Mar → Jun 2022 | Clostridium difficile colitis | National Institute of Medical Sciences and Nutrition Salvador Zubiran | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Microbiota capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07496502 ↗ |
| Modality | Other / unclassified | “Oral capsules containing frozen intestinal microbiota derived from healthy donors” NCT07496502 ↗ |
| Route | Oral | “Participants received frozen, encapsulated intestinal microbiota from screened donors or identical placebo capsules orally during hospitalization.” NCT07496502 ↗ |